YOUR RESOURCE TO FIND THE:
Product Code • NDCs in Billing Format • ICD-10 Code • Administration Code(s) • CVX Code
The information provided in this resource is for informational purposes only. Every reasonable effort has been made to verify the accuracy of the information; however, this resource is not intended to provide specific guidance on how to utilize, code, bill, or charge for any product or service. Health care providers should make the ultimate decision as to when to use a specific product based on clinical appropriateness for a particular patient. Third-party payment for medical products and services is affected by numerous factors, and Sanofi Pasteur Inc. cannot guarantee success in obtaining insurance payments.
SANOFI PASTEUR VACCINES | ||||||||
---|---|---|---|---|---|---|---|---|
National Drug Code (NDC) | ||||||||
Product | Product Description | # of Componentsa |
When the Payer Requires the Outer Carton NDC | When the Payer Requires the Unit-of-Use NDC (Vial or Syringe) | Product CPT®b Code |
ICD-10c Code |
CVX Code |
MVX Code |
ActHIB® | Haemophilus b Conjugate (Tetanus Toxoid Conjugate) | 1 | N449281054503 UN1 | N449281054758 UN1 | 90648 | Z23 | 48 | PMC |
Adacel® | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed |
3 | N449281040010 ML0.5 N449281040020 ML0.5 N449281040015 ML0.5 |
N449281040058 ML0.5 N449281040089 ML0.5 N449281040088 ML0.5 |
90715 | Z23d | 115 | PMC |
DAPTACEL® | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed |
3 | N449281028610 ML0.5 | N449281028658 ML0.5 | 90700 | Z23 | 106 | PMC |
Diphtheria and Tetanus | Diphtheria and Tetanus Toxoids Adsorbed | 2 | N449281022510 ML0.5 | N449281022558 ML0.5 | 90702 | Z23 | 28 | PMC |
Imogam® Rabies-HT | Rabies Immune Globulin (Human) USP, Heat Treated | N/A | N449281019020 MLX.Xe | N449281019058 MLX.Xe | 90376e | Z20.3 | 34 | PMC |
IMOVAX® RABIES | Rabies Vaccine | 1 | N449281025051 UN1 N449281025251 UN1 |
N449281024858 UN1 N449281024658 UN1 |
90675 | Z23d | 175 | PMC |
IPOL® | Poliovirus Vaccine Inactivated | 1 | N449281086010 ML0.5 | N449281086078 ML0.5 | 90713 | Z23 | 10 | PMC |
Menactra® | Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine |
1 | N449281058905 ML0.5 | N449281058958 ML0.5 | 90734 | Z23 | 114 | PMC |
MenQuadfi® | Meningococcal (Groups A, C, Y, W) Conjugate Vaccine | 1 | N449281059005 ML0.5 | N449281059058 ML0.5 | 90619 | Z23 | 203 | PMC |
Pentacel® | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus andHaemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine |
5 | N449281051005 UN1 N449281051105 UN1 |
N449281054858f UN1 N449281054515f UN1 N449281054458 UN1 |
90698 | Z23 | 120 | PMC |
Quadracel® | Diptheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine |
4 | N449281056210 ML0.5 | N449281056258 ML0.5 | 90696 | Z23 | 130 | PMC |
TENIVAC® | Tetanus and Diphtheria Toxoids Adsorbed | 2 | N449281021510 ML0.5 N449281021515 ML0.5 |
N449281021558 ML0.5 N449281021588 ML0.5 |
90714 | Z23d | 113 | PMC |
TUBERSOL® | Tuberculin Purified Protein Derivative (Mantoux) | N/A | N449281075221 ML0.1 N449281075222 ML0.1 |
N449281075278 ML0.1 N449281075298 ML0.1 |
86580 | Z11.1 | N/A | PMC |
Typhim Vi® | Typhoid Vi Polysaccharide Vaccine | 1 | N449281079051 ML0.5 N449281079020 ML0.5 |
N449281079088 ML0.5 N449281079038 ML0.5 |
90691 | Z23 | 101 | PMC |
VAXELIS™ | Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine |
6 | N463361024310 ML0.5 N463361024315 ML0.5 |
N463361024358 ML0.5 N463361024388 ML0.5 |
90697 | Z23 | 146 | MSP |
YF-VAX® | Yellow Fever Vaccine | 1 | N449281091505 UN1 N449281091501 UN1 |
N449281091568 UN1 N449281091558 UN1 |
90717 | Z23 | 37 | PMC |
MERCK | ||||||||
---|---|---|---|---|---|---|---|---|
National Drug Code (NDC) | ||||||||
Product | Product Description | # of Componentsa | When the Payer Requires the Outer Carton NDC | When the Payer Requires the Unit-of-Use NDC (Vial or Syringe) | Product CPT®b Code | ICD-10c Code | CVX Code | MVX Code |
Gardisil® 9 | Human Papillomavirus 9-valent Vaccine, Recombinant | 3 | N400006412102 ML0.5 | N400006412101 ML0.5 | 90651 | Z23 | 165 | MSD |
M-M-R II® | Measles, Mumps and Rubella Virus Vaccine Live | 1 | N400006468100 UN1 | N400006468101 UN1 | 90707 | Z23 | 3 | MSD |
PedvaxHIB® | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) | 1 | N400006489700 ML0.5 | N400006489701 ML0.5 | 90647 | Z23 | 49 | MSD |
Pneumovax® 23 | Pneumococcal Vaccine Polyvalent | 4 | N400006494300 ML0.5 N400006483703 ML0.5 |
N400006494301 ML0.5 N400006483701 ML0.5 |
90732 | Z23 | 33 | MSD |
ProQuad® | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | 1 | N400006417100 UN1 | N400006417101 UN1 | 90710 | Z23 | 94 | MSD |
Recombivax HB® | Hepatitis B Vaccine (Recombinant): AdultDosage | 1 | N400006499500 ML1 N400006499541 ML1 N400006409402 ML1 |
N400006499501 ML1 N400006499501 ML1 N400006409401 ML1 |
90746-Adults 90743-Adolescents 90740-Dialysis |
Z23 | 43 (44 dialysis) 08 | MSD |
Recombivax HB® | Hepatitis B Vaccine (Recombinant): Pediatric/Adolescent Dosage | 1 | N400006409302 ML0.5 N400006498100 ML0.5 |
N400006409301 ML0.5 N400006498101 ML0.5 |
90744 | Z23 | 116 | MSD |
RotaTeq® | Rotavirus Vaccine, Live, Oral, Pentavalent | 1 | N400006404720 ML0.5 N400006404741 ML0.5 |
N400006404701 ML0.5 N400006404701 ML0.5 |
90680 | Z23 | 21 | MSD |
Varivax® | Varicella Virus Vaccine Live | 1 | N400006482700 UN1 | N400006482701 UN1 | 90716 | Z23 | 52 | MSD |
Vaqta® | Hepatitis A Vaccine, Inactivated: Adult Dosage | 1 | N400006484141 ML1 N400006409602 ML1 |
N400006484101 ML1 N400006409601 ML1 |
90632 | Z23 | 83 | MSD |
Vaqta® | Hepatitis A Vaccine, Inactivated: Pediatric/Adolescent Dosage | 1 | N400006483141 ML0.5 N400006409502 ML0.5 |
N400006483101 ML0.5 N400006409501 ML0.5 |
90633 | Z23 | 121 | MSD |
PFIZER | ||||||||
---|---|---|---|---|---|---|---|---|
National Drug Code (NDC) | ||||||||
Product | Product Description | # of Componentsa | When the Payer Requires the Outer Carton NDC | When the Payer Requires the Unit-of-Use NDC (Vial or Syringe) | Product CPT®b Code | ICD-10c Code | CVX Code | MVX Code |
Prevnar 13® | Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) | 1 | N400005197102 ML0.5 N400005197105 ML0.5 |
N400005197101 ML0.5 N400005197101 ML0.5 |
90670 | Z23 | 133 | PFR |
Trumenba® | Meningococcal Group B Vaccine | 1 | N400005010005 ML0.5 | N400005010001 ML0.5 | 90621 | Z23 | 162 | PFR |
GLAXOSMITHKLINE | ||||||||
---|---|---|---|---|---|---|---|---|
National Drug Code (NDC) | ||||||||
Product | Product Description | # of Componentsa | When the Payer Requires the Outer Carton NDC | When the Payer Requires the Unit-of-Use NDC (Vial or Syringe) | Product CPT®b Code | ICD-10c Code | CVX Code | MVX Code |
Kinrix® | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine |
4 | N400005197102 ML0.5 N400005197105 ML0.5 |
N400005197101 ML0.5 N400005197101 ML0.5 |
90670 | Z23 | 133 | SKB |
Pediarix® | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine |
5 | N400005010005 ML0.5 | N400005010001 ML0.5 | 90621 | Z23 | 162 | SKB |
Infanrix® | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed |
3 | N458160081011 ML0.5 N458160081052 ML0.5 |
N458160081001 ML0.5 N458160081043 ML0.5 |
90700 | Z23 | 20 | SKB |
Twinrix® | Hepatitis A & Hepatitis B (Recombinant) Vaccine | 2 | N458160081552 ML1 | N458160081543 ML1 | 90636 | Z23 | 104 | SKB |
Havrix® | Hepatitis A Vaccine: Adult Dosage | 1 | N458160082652 ML1 | N458160082643 ML1 | 90632 | Z23 | 52 | SKB |
Havrix® | Hepatitis A Vaccine: Pediatric /Adolescent Dosage |
1 | N458160082552 ML0.5 | N458160082543 ML0.5 | 90633 | Z23 | 83 | SKB |
Engerix-B® | Hepatitis B Vaccine (Recombinant): AdultDosage | 1 | N458160082111 ML1 N458160082152 ML1 |
N458160082101 ML1 N458160082143 ML1 |
90746 -Adults 90747 - Dialysis |
Z23 | 43 (44 dialysis) |
SKB |
Engerix-B® | Hepatitis B Vaccine (Recombinant): Pediatric/Adolescent Dosage |
1 | N458160082052 ML0.5 | N458160082043 ML0.5 | 90744 | Z23 | 8 | SKB |
Menveo® | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
1 | N458160095509 UN1 | N458160095801 UN1 | 90734 | Z23 | 136 | SKB |
Bexsero® | Meningococcal Group B Vaccine | 1 | N458160097620 ML0.5 | N458160097602 ML0.5 | 90620 | Z23 | 163 | SKB |
Hiberix® | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
1 | N458160081811 UN1 | N458160081605 UN1 | 90648 | Z23 | 48 | SKB |
Rotarix® | Rotavirus Vaccine, Live, Oral | 1 | N458160085452 UN1 | N458160085101 UN1 | 90681 | Z23 | 119 | SKB |
Boostrix® | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
3 | N458160084252 ML0.5 N458160084211 ML0.5 |
N458160084243 ML0.5 N458160084201 ML0.5 |
90715 | Z23d | 115 | SKB |
Shingrix® | Zoster Vaccine Recombinant, Adjuvanted | 1 | N458160081912 UN1 N458160082311 UN1 |
N458160082801UN1 N458160082803 UN1 |
90750 | Z23 | 187 | SKB |
DYNAVAX | ||||||||
---|---|---|---|---|---|---|---|---|
National Drug Code (NDC) | ||||||||
Product | Product Description | # of Componentsa | When the Payer Requires the Outer Carton NDC | When the Payer Requires the Unit-of-Use NDC (Vial or Syringe) | Product CPT®b Code | ICD-10c Code | CVX Code | MVX Code |
Heplisav-B® | Hepatitis B Vaccine (Recombinant), Adjuvanted | 1 | N443528000305 ML.05 | N443528000301 ML.05 | 90739 | Z23 | 189 | DVX |
VALNEVA | ||||||||
---|---|---|---|---|---|---|---|---|
National Drug Code (NDC) | ||||||||
Product | Product Description | # of Componentsa | When the Payer Requires the Outer Carton NDC | When the Payer Requires the Unit-of-Use NDC (Vial or Syringe) | Product CPT®b Code | ICD-10c Code | CVX Code | MVX Code |
Ixiaro® | Japanese Encephalitis Vaccine, Inactivated, Adsorbed |
1 | N442515000201 ML0.25 N442515000201 ML0.5 |
N442515000200 ML0.25 N442515000200 ML0.5 | 90738 | Z23 | 134 | VAL |
aA component refers to all antigens in a vaccine that prevent disease caused by 1 organism.
bCPT (Current Procedural Terminology) is a registered trademark of the American Medical Association.
c ICD 10 = International Classification of Disease, 10th Revision.
d When tetanus or rabies products are given as part of clinical management, use a primary ICD-10 code which describes the patient’s condition.
e Coding for RIG is based on the units administered. Bill a unit of service for each milliliter administered, rounding up or down as appropriate when the milliliters administered are not a whole number. For example, 9.9 milliliters is rounded up and billed as 10 units of service. For NDC reporting, the units dispensed in this example would be ML9.9. Refer to Reimbursement Information on VaccineShoppe.com® for further assistance.
f There are 2 possible NDCs for the Hib component of this vaccine. Use the NDC that is on the product you administered.
Some payers require an NDC in addition to the CPT code for the product. In such cases, it is important to format the NDC correctly or the claim will be denied, and you will need to resubmit a corrected claim in order to be reconsidered for payment. The grid on the inside of this guide provides the NDCs for all Sanofi Pasteur products in billing format.
First confirm with your payer if they require the carton NDC, the unit-of-use (vial or syringe) NDC, or if they will accept either. When an NDC is required, enter the following in line 24A of the claim form:
- Start with qualifier N4, and, with no space, follow immediately with the 11-digit NDC number (no hyphens).
- To convert Sanofi Pasteur products to the required 11-digit format, add a leading zero in the middle section of numbers (ex. 49281-545-03 = 49281-0545-03).
- After a space, follow the NDC with the Unit of Measure and Units Dispensed.
- If the product is reconstituted, use Unit of Measure UN followed by the number of units dispensed with no space. Example: UN1 signifies that 1 unit of reconstituted pr oduct was administered.
- If the product is supplied in a liquid format, use the Unit of Measure ML, and the Units Dispensed is the actual decimal quantity administered with no space.
The codes used to populate registries are CVX codes, which indicate the product used in a vaccination, and MVX codes, which indicate the manufacturer of the vaccine. When a MVX (manufacturer) code is paired with a CVX (vaccine administered) code, the specific trade named vaccine can be identified.
An immunization administration code must be reported in addition to the vaccine or toxoid product code in order to be paid for the administration service. There are 2 code sets that may be used when billing for administration, depending on the age of the patient and whether or not qualified counseling was performed.
If the patient is 18 years of age or under, and counseling was performed by the physician or other qualified health care professional, component-based administration codes are used. These codes are based on the number of components in the vaccine, and a unit of administration is billed for each component. A component is defined as each disease for which the vaccine is intended to provide protection. These codes apply to all routes of administration, including injectable, intranasal, and oral.
- 90460 — Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional;first or only component of each vaccine or toxoid administered.
- +90461 — Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered.
Example: IIV4, a single-component vaccine, is administered to a pediatric patient and the physician provides face-to-face counseling. Administration is billed using 1 unit of 90460.
Example: DTaP-IPV/Hib, a 5-component vaccine, is administered to pediatric patient and face-to-face counseling is provided by the nurse practitioner. Administration is billed using 1 unit of 90460 and 4 units of 90461.
If the patient is 19 years of age or over, or if they are 18 years of age or under and qualified counseling was not performed, use the code set that is based on number of vaccinations administered at that visit.
- 90471 — Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)
- +90472 — Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/ toxoid)
- 90473 — Immunization administration by oral or intranasal route; 1 vaccine (single or combination vaccine/toxoid)
- +90474 — Immunization administration by oral or intranasal route; each additional vaccine (single or combination vaccine/toxoid)
Example: IIV4 and Tdap vaccines are administered to an adult patient. Bill 1 unit of 90471 for administering the IIV4 vaccine and 1 unit of 90472 for administering the Tdap vaccine.
If the patient is covered by Medicare Part B you must use codes G0008, G0009, or G0010 when billing for administration of influenza, pneumococcal, or hepatitis B vaccines.
- G0008 — Administration of influenza virus vaccine
- G0009 — Administration of pneumococcal vaccine
- G0010 — Administration of hepatitis B vaccine
Example: IIV4-HD and PCV13 vaccines are administered to a Medicare patient. Bill G0008 for administering the IIV4-HD vaccine and G0009 for administering the PCV13 vaccine.
Verify that you are billing the proper administration code based on the patient encounter. There are different administration codes for different circumstances. Choose the correct code for each circumstance.
Patients 0-18 Years of Age With Qualified Counseling | Patients 0-18 Years of Age Without Qualified Counseling | Patients 19 Years of Age and Older With or Without Qualified Couseling | |
---|---|---|---|
90460 x (# of vaccines administered at the visit) | X | ||
90461 x (# of additional components within the vaccines administered at the visit) | X | ||
90471 x 1 [first vaccine administered at the visit] | X | X | |
90472 x (# of additional vaccines administered at the visit) | X | X |
The administration code for Imogam Rabies-HT is CPT 96372. Bill one unit for each syringe used. No administration code is billed with Tubersol.
A visit may be billed only if it was for a separate and significant reason, not otherwise related to the product administration. Health plans which follow Correct Coding Initiative (CCI) edits may require that modifier -25 be attached in order to be paid for the visit and the administration service.
Modifier -25 should be attached to the CPT code for the visit and an ICD-10 code(s) which describes the reason for the visit should be used. It is important to use modifier-25 and accurate ICD-10 code(s) for the visit as they support the health plan’s reimbursement for the visit.
As usual, the code(s) for the product and administration should be billed using the appropriate CPT and ICD-10 codes. Modifier -25 is only used with the visit code.